N. Watson

发表

The importance of general practitioner information in selection of volunteers for clinical trials.

N. Watson, P. Wyld, 1992, British journal of clinical pharmacology.

Levormeloxifene: safety, pharmacodynamics and pharmacokinetics in healthy postmenopausal women following single and multiple doses of a new selective oestrogen receptor modulator.

N. Watson, B. Kiehr, K. Bjarnason, 2002, British journal of clinical pharmacology.

Sevelamer Hydrochloride (Renagel®), a Nonabsorbed Phosphate‐Binding Polymer, Does Not Interfere with Digoxin or Warfarin Pharmacokinetics

Carlo Incerti, M. Plone, N. Watson, 2001, Journal of clinical pharmacology.

A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers.

R. Gristwood, N. Watson, W. Nimmo, 2002, British journal of clinical pharmacology.

Comparison of the pharmacokinetics of crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women(3).

N. Watson, H. Levine, H. Levine, 2000, Fertility and sterility.

The local anaesthetic activity of levobupivacaine does not differ from racemic bupivacaine (Marcain): first clinical evidence.

R. Gristwood, N. Watson, W. Nimmo, 1997, Expert opinion on investigational drugs.

What a Clinical Pharmacologist Requires from Toxicokinetic Studies

N. Watson, W. Nimmo, 1994 .

Pharmacokinetic study of chloramphenicol in calves using sensitive gas-liquid chromatographic analysis.

W. Black, N. Watson, 1986, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

The Ethical Use of Human Volunteers in Clinical Research

N. Watson, W. Nimmo, 1996 .